These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 101819

  • 21. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B.
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [Abstract] [Full Text] [Related]

  • 22. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H, Dudczak R, Lechner K.
    Dtsch Med Wochenschr; 1973 Nov 30; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A, Bruch HP, Hörl M, Düsel W.
    Prog Clin Biol Res; 1987 Nov 30; 242():439-44. PubMed ID: 2959966
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG, Nelson SR, Hampton KK, Casali B, Boothby M, Prentice CR.
    Blood Coagul Fibrinolysis; 1990 Oct 30; 1(4-5):385-8. PubMed ID: 2133215
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease].
    Engelken HJ, Martin M.
    Med Welt; 1974 Jun 21; 25(25):1122-4. PubMed ID: 4418430
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
    Leschke M, Schoebel FC, Strauer BE.
    Clin Hemorheol Microcirc; 1997 Jun 21; 17(1):59-66. PubMed ID: 9181759
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B, Doppelfeld E.
    Med Klin; 1978 May 26; 73(21):791-7. PubMed ID: 651768
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Magnetic resonance imaging studies on the effect of the fibrinogen-lowering agent ancrod on cerebral lesions in two rat models of acute stroke.
    Elger B, Laux V, Schwarz M.
    Arzneimittelforschung; 1997 Aug 26; 47(8):895-9. PubMed ID: 9296273
    [Abstract] [Full Text] [Related]

  • 36. [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].
    Ehringer H, Dudczak E, Lechner K, Widhalm F.
    Verh Dtsch Ges Inn Med; 1972 Aug 26; 78():624-7. PubMed ID: 4677225
    [No Abstract] [Full Text] [Related]

  • 37. [Simultaneous measurement of indirect (Doppler-ultrasonic-technique) and direct arterial systolic blood pressure of the human radial artery (author's transl)].
    Köhler M, Lösse B.
    Z Kardiol; 1979 Aug 26; 68(8):551-6. PubMed ID: 506365
    [Abstract] [Full Text] [Related]

  • 38. Conventional uses of heparin.
    McNicol GP.
    Thromb Diath Haemorrh; 1975 Feb 28; 33(1):97-101. PubMed ID: 1091023
    [No Abstract] [Full Text] [Related]

  • 39. Failure of ancrod in the treatment of heparin-induced arterial thrombosis.
    Lewis BE, Leya FS, Wallis D, Grassman E.
    Can J Cardiol; 1994 Jun 28; 10(5):559-61. PubMed ID: 8012887
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.